News for Novo Nordisk A/S (NVO)

As of March 11, 2025, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading...

NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (:

NVO Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, March 10, 2025 (GLOBE NEWSWIRE) -- Novo Nordisk A/S (: NVO) is facing a class-action

Novo Nordisk A/S's CagriSema faces challenges, yet new trials aim to enhance efficacy, rival Eli Lilly in obesity treatments, and stay competitive. Click for more.

Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.

NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Novo Nordisk A/S (: NVO)?Did you purchase your shares

U.S. stock futures were lower this morning, with the Dow futures falling around 1% on Monday. Shares of Rocket Companies, Inc. RKT fell sharply in today's pre-...

PR NewswireNEW YORK, March 10, 2025 NEW YORK, March 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Novo Nordisk

NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (:

Novo Nordisk is cutting the price of its weight-loss drug, Wegovy, and selling it through a direct-to-patient online pharmacy to reach more people who aren't covered.

South Africa's Competition Commission investigates Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market.

NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S

Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), The Coca-Cola Company (KO) and Wells Fargo & Company (WFC), as well as a micro-cap stock Star Group, L.P. (SGU).

The following slide deck was published by Novo Nordisk A/S in conjunction with their 2024 Q4 earnings call.

NVO Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, March 03, 2025 (GLOBE NEWSWIRE) -- Novo Nordisk A/S (: NVO) is facing a class-action

PR NewswireNEW YORK, March 3, 2025 NEW YORK, March 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Novo

NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Novo Nordisk A/S (: NVO). Shareholders who pur

Recently, Zacks.com users have been paying close attention to Novo Nordisk (NVO). This makes it worthwhile to examine what the stock has in store.

On March 3, 2025, Bernstein Liebhard LLP, a prominent investor rights law firm, announced a securities fraud class action lawsuit against Novo Nordisk AS (NVO).